Dermonecrosis caused by a spitting cobra snakebite results from toxin potentiation and is prevented by the repurposed drug varespladib.

MLA

Bartlett, Keirah E., et al. “Dermonecrosis Caused by a Spitting Cobra Snakebite Results from Toxin Potentiation and Is Prevented by the Repurposed Drug Varespladib.” Proceedings of the National Academy of Sciences of the United States of America, vol. 121, no. 19, May 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1073/pnas.2315597121.

APA

Bartlett, K. E., Hall, S. R., Rasmussen, S. A., Crittenden, E., Dawson, C. A., Albulescu, L.-O., Laprade, W., Harrison, R. A., Saviola, A. J., Modahl, C. M., Jenkins, T. P., Wilkinson, M. C., Gutiérrez, J. M., & Casewell, N. R. (2024). Dermonecrosis caused by a spitting cobra snakebite results from toxin potentiation and is prevented by the repurposed drug varespladib. Proceedings of the National Academy of Sciences of the United States of America, 121(19), 1–12. https://doi.org/10.1073/pnas.2315597121

Chicago

Bartlett, Keirah E., Steven R. Hall, Sean A. Rasmussen, Edouard Crittenden, Charlotte A. Dawson, Laura-Oana Albulescu, William Laprade, et al. 2024. “Dermonecrosis Caused by a Spitting Cobra Snakebite Results from Toxin Potentiation and Is Prevented by the Repurposed Drug Varespladib.” Proceedings of the National Academy of Sciences of the United States of America 121 (19): 1–12. doi:10.1073/pnas.2315597121.